| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $6.4M | +181.5% |
| R&D Expense | $65.6M | +3.0% |
| SG&A Expense | $28.2M | -7.8% |
| Operating Income | -$121.9M | -32.6% |
| Pre-tax Income | -$116.6M | -39.8% |
| Income Tax | $637K | +351.8% |
| Net Income | -$117.3M | -40.3% |
| EPS (Basic) | -$12.48 | -33.2% |
| EPS (Diluted) | -$12.48 | -33.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $21.8M | -60.8% |
| Short-term Investments | $53.3M | -24.3% |
| Accounts Receivable | $969K | -42.9% |
| Current Assets | $82.4M | -37.4% |
| Total Assets | $113.5M | -49.8% |
| Current Liabilities | $11.9M | -20.2% |
| Total Liabilities | $62.1M | -5.7% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$78.6M | -30.8% |
| Capital Expenditures | $518K | -97.1% |
| Investing Cash Flow | $44.0M | +135.7% |
| Financing Cash Flow | $685K | -99.0% |
| Free Cash Flow | -$79.1M | -1.4% |
| $51.4M |
| -67.9% |